JP2021059605A5 - - Google Patents

Download PDF

Info

Publication number
JP2021059605A5
JP2021059605A5 JP2021004728A JP2021004728A JP2021059605A5 JP 2021059605 A5 JP2021059605 A5 JP 2021059605A5 JP 2021004728 A JP2021004728 A JP 2021004728A JP 2021004728 A JP2021004728 A JP 2021004728A JP 2021059605 A5 JP2021059605 A5 JP 2021059605A5
Authority
JP
Japan
Prior art keywords
approximately
weeks
composition
hours
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021004728A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021059605A (ja
JP7108724B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2021059605A publication Critical patent/JP2021059605A/ja
Publication of JP2021059605A5 publication Critical patent/JP2021059605A5/ja
Application granted granted Critical
Publication of JP7108724B2 publication Critical patent/JP7108724B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021004728A 2012-03-30 2021-01-15 末梢神経損傷を処置するためのニューレグリンの使用 Expired - Fee Related JP7108724B2 (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US61/618,381 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US61/674,060 2012-07-20
US201261693589P 2012-08-27 2012-08-27
US201261693585P 2012-08-27 2012-08-27
US61/693,585 2012-08-27
US61/693,589 2012-08-27
US201361785419P 2013-03-14 2013-03-14
US61/785,419 2013-03-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019070976A Division JP2019131582A (ja) 2012-03-30 2019-04-03 末梢神経損傷を処置するためのニューレグリンの使用

Publications (3)

Publication Number Publication Date
JP2021059605A JP2021059605A (ja) 2021-04-15
JP2021059605A5 true JP2021059605A5 (https=) 2021-09-24
JP7108724B2 JP7108724B2 (ja) 2022-07-28

Family

ID=48128617

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015503646A Expired - Fee Related JP6420233B2 (ja) 2012-03-30 2013-03-29 末梢神経損傷を処置するためのニューレグリンの使用
JP2017076415A Pending JP2017149746A (ja) 2012-03-30 2017-04-07 末梢神経損傷を処置するためのニューレグリンの使用
JP2019070976A Pending JP2019131582A (ja) 2012-03-30 2019-04-03 末梢神経損傷を処置するためのニューレグリンの使用
JP2021004728A Expired - Fee Related JP7108724B2 (ja) 2012-03-30 2021-01-15 末梢神経損傷を処置するためのニューレグリンの使用

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2015503646A Expired - Fee Related JP6420233B2 (ja) 2012-03-30 2013-03-29 末梢神経損傷を処置するためのニューレグリンの使用
JP2017076415A Pending JP2017149746A (ja) 2012-03-30 2017-04-07 末梢神経損傷を処置するためのニューレグリンの使用
JP2019070976A Pending JP2019131582A (ja) 2012-03-30 2019-04-03 末梢神経損傷を処置するためのニューレグリンの使用

Country Status (15)

Country Link
US (3) US20150094263A1 (https=)
EP (3) EP3842059A1 (https=)
JP (4) JP6420233B2 (https=)
CN (2) CN104321072A (https=)
AU (4) AU2013237896B2 (https=)
BR (1) BR112014024308B1 (https=)
CA (1) CA2869070A1 (https=)
DK (2) DK3278811T3 (https=)
ES (2) ES2647917T3 (https=)
IL (3) IL288785B2 (https=)
MX (1) MX354598B (https=)
NZ (1) NZ700546A (https=)
PL (2) PL2830645T3 (https=)
PT (2) PT2830645T (https=)
WO (1) WO2013149163A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166068A1 (en) 2008-07-17 2011-07-07 Acorda Therapeutics, Inc. Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure
NZ625673A (en) 2009-10-14 2015-11-27 Acorda Therapeutics Inc Use of a neuregulin to treat peripheral nerve injury
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
WO2017096358A1 (en) * 2015-12-04 2017-06-08 University Of Iowa Research Foundation Apparatus, systems and methods for predicting, screening and monitoring of encephalopathy / delirium
US11511136B2 (en) 2017-11-17 2022-11-29 The Research Foundation For The State University Of New York Method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
WO2021022254A2 (en) * 2019-08-01 2021-02-04 Mark Evans Methods and apparatus for reducing the risk, and identifying the existence, of neurological injury to a human fetus during and before labor
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US888A (en) 1838-08-20 perkins
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
AU745324B2 (en) * 1997-10-14 2002-03-21 Cenes Pharmaceuticals, Inc. Therapeutic methods comprising use of a neuregulin
AU2001274947B2 (en) * 2000-05-23 2006-08-17 Acorda Therapeutics, Inc. Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US20100286043A1 (en) * 2007-10-05 2010-11-11 Tufts Medical Center, Inc. Use of neuregulin-1 in reducing brain damage
WO2009108390A2 (en) * 2008-02-29 2009-09-03 Acorda Therapeutics, Inc. Method for achieving desired glial growth factor 2 plasma levels
US20110166068A1 (en) * 2008-07-17 2011-07-07 Acorda Therapeutics, Inc. Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure
KR101237927B1 (ko) * 2009-05-07 2013-03-04 (주)문엔제이 신경손상 및 신경질환 예방 또는 치료용 약학조성물
NZ625673A (en) * 2009-10-14 2015-11-27 Acorda Therapeutics Inc Use of a neuregulin to treat peripheral nerve injury
EP2603221A4 (en) * 2010-08-13 2014-02-26 Univ Georgetown GGF2 AND METHOD FOR ITS APPLICATION

Similar Documents

Publication Publication Date Title
JP2021059605A5 (https=)
TWI445531B (zh) 大麻素組合物之抗腫瘤功效
Baker et al. Osteocutaneous free scapular flap for one-stage mandibular reconstruction
Bianchi et al. Iliac crest free flap for maxillary reconstruction
RU2638795C2 (ru) Способ введения противоопухолевого агента
SHIKATA et al. Surgical treatment of giant-cell tumors of the spine
JP2015514096A5 (https=)
Dai et al. Titanium mesh shaping and fixation for the treatment of comminuted mandibular fractures
Sanford et al. Hemangioblastoma of the cervicomedullary junction: report of three cases
Pack et al. Osteosarcoma of the mandible arising in fibrous dysplasia—a case report
Aragaki et al. Ramucirumab-related oral pyogenic granuloma: A report of two cases
JP7536364B2 (ja) 骨軟部腫瘍の治療用医薬組成物
Vermesan et al. Secondary pathologic fractures in osteosarcoma: prognosis and evolution
Osguthorpe et al. Benign osteoblastoma of the maxillary sinus
RU2428948C1 (ru) Способ фиксации двух верхних шейных позвонков
Geiger et al. Use of neoadjuvant pexidartinib with limb salvage surgery for diffuse tenosynovial giant cell tumor: a case report
Tavassol et al. Serratus anterior free flap in oral reconstruction
Edstrom et al. Prosthetic appliance for oronasal communication obturation in a dog
RU2146888C1 (ru) Способ лечения варикоцеле
Ellis et al. Osteomyelitis, iatrogenic osteolysis, pathologic fracture, and bone graft: Report of a case
Dierks et al. Segmental resection of the anterior mandibular arch with fibular microvascular reconstruction
Lim et al. Retrospective analysis of vascularised free fibula grafts in oromandibular reconstruction and dental rehabilitation following resection of ameloblastoma
Issa et al. Extensive submandibular desmoid fibromatosis in a pediatric patient: a therapeutic challenge
Walsh et al. Partial cranial internal hemipelvectomy in a feline patient with ilial osteosarcoma–a case report
Likhanova et al. EXPERIENCE IN USING IMPLANTS MADE OF POROUS TITANIUM NICKELIDE IN MIDFACIAL RECONSTRUCTION SURGERY